Li Kang Biomedical Dividends and Buybacks
Dividend criteria checks 2/6
Li Kang Biomedical is a dividend paying company with a current yield of 5.79%.
Key information
5.8%
Dividend yield
-16.4%
Buyback Yield
| Total Shareholder Yield | -10.6% |
| Future Dividend Yield | n/a |
| Dividend Growth | 10.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$2.500 |
| Payout ratio | 91% |
Recent dividend and buyback updates
Recent updates
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger
Apr 19
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?
Mar 09Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 09The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About
Jan 19We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt
Dec 29Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend
Dec 08Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 6242 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6242's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
| Li Kang Biomedical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (6242) | 5.8% |
| Market Bottom 25% (TW) | 1.7% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Personal Products) | 4.8% |
| Analyst forecast (6242) (up to 3 years) | n/a |
Notable Dividend: 6242's dividend (5.79%) is higher than the bottom 25% of dividend payers in the TW market (1.75%).
High Dividend: 6242's dividend (5.79%) is in the top 25% of dividend payers in the TW market (4.51%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (90.6%), 6242's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (119.3%), 6242's dividend payments are not well covered by cash flows.